Lidokain "Aguettant" 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

lidokain "aguettant" 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte

laboratoire aguettant - lidocainhydrochloridmonohydrat - injektionsvæske, opløsning i fyldt injektionssprøjte - 10 mg/ml

Lidokain "Aguettant" 20 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

lidokain "aguettant" 20 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte

laboratoire aguettant - lidocainhydrochloridmonohydrat - injektionsvæske, opløsning i fyldt injektionssprøjte - 20 mg/ml

Waylivra Unió Europea - danès - EMA (European Medicines Agency)

waylivra

akcea therapeutics ireland limited - volanesorsen natrium - hyperlipoproteinæmi type i - andre lipid ændring af agenter - waylivra er indiceret som et supplement til kosten i voksne patienter med genetisk bekræftet familiær chylomicronemia syndrom (fcs) og høj risiko for pancreatitis, i, som reaktion på kost og sænke triglycerid terapi har været utilstrækkelig.

Alendronate/Cholecalciferol "Accord" 70 mg+70 mikrogram tabletter Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

alendronate/cholecalciferol "accord" 70 mg+70 mikrogram tabletter

accord healthcare b.v. - alendronsyre, cholecalciferoltrituration - tabletter - 70 mg+70 mikrogram

Spikevax (previously COVID-19 Vaccine Moderna) Unió Europea - danès - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Vydura Unió Europea - danès - EMA (European Medicines Agency)

vydura

pfizer europe ma eeig  - rimegepant - migræneforstyrrelser - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.

Eladynos Unió Europea - danès - EMA (European Medicines Agency)

eladynos

theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - calciumhomeostase - behandling af osteoporose hos postmenopausale kvinder med øget risiko for brud.

Bonjesta 20+20 mg tabletter med modificeret udløsning Dinamarca - danès - Lægemiddelstyrelsen (Danish Medicines Agency)

bonjesta 20+20 mg tabletter med modificeret udløsning

exeltis healthcare s.l - doxylaminhydrogensuccinat, pyridoxinhydrochlorid - tabletter med modificeret udløsning - 20+20 mg